Attorneys say agency’s president has no legal basis for asking the Enlarged Board of Appeal to review the finding that plants produced by biological processes are patentable.
In a period of marked change at the board, early numbers suggest the Supreme Court’s landmark decision is leading to greater discretion among petitioners
The high invalidation rate for life science patents in China has created a headache for drug companies and a money-making opportunity for enterprising individuals
Two senior members of the Ericsson IP team argue that innovators involved in wireless standardisation currently face impossible choices that lead to over-declaration or potential loss of enforceability
With outline of proposed subject matter eligibility bill expected this month latest key Federal Circuit ruling ratchets up the pressure on Congressional action
Firms welcomed tougher measures against infringers at IPBC Korea 2019 last week, but there are concerns about a recent initiative to attract more foreign litigants through the use of English-language hearings
Everything you need to know about the major news stories in the life sciences sector that broke last month
Judges rule that inventions arrived at by well-established or routine tests can be patented, but the decision will also reassure generics
German car giant brings complaint against Finnish company in effort to get clarification around licensing of mobile standard essential patents in the auto sector
With so many issues emerging across the entire supply chain, the sector’s IP leaders will be sharing their thoughts and insights at events in Detroit and Munich next month
Number of petitions slumps in the first quarter as petitioners and patent owners come to terms with 12 months of change at the board
What the latest Federal Circuit 101 decision means for the medical diagnostics sector.
Storm clouds are gathering over the most talked about company in the telecoms sector but as we embark on a new era of mobile technology, Huawei still enjoys a number of notable advantages.
Regulations in the special economic zone once known primarily as a den of piracy will allow fast-track administrative injunctions and impose stiff penalties on repeat infringers
China’s healthcare sector is booming and while the patent system has developed considerably in recent years, pharmaceutical companies should still think carefully about how to protect their rights.